Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Claire Long

- PMLiVE

Winning the war against cancer

Dr Josep Figueras on survival, access to treatments and the need for good data in oncology

- PMLiVE

Seattle Genetics signs $2bn deal for Immunomedics’ cancer drug

Buys rights to breast cancer drug candidate that could be be in line for FDA approval by year end

- PMLiVE

Stada confirms Cinven as one of two takeover bidders

Private equity group offers €3.6bn for the generics and over-the-counter medicines manufacturer

A view from within #LucidLife

As we celebrate our 10 year anniversary, Joanne shares her #LucidLife journey

Lucid Group Communications Limited

- PMLiVE

Global standard for medical writing outlined

International writers' associations aim to strengthen and share best practice

- PMLiVE

McCann Health appoints London and New York heads

Mark Archer and Jamie Avallone both become managing directors

- PMLiVE

Cognite bolsters creative and account teams

David Sartain and Cassandra Johnson join the agency

Deal Watch January 2017

Actelion, Johnson & Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up

Lundbeck partners with IBM Watson on drug research

The deal will also see it set up a new real world evidence platform

Sanofi reception

Praluent can stay on market for now, says US court

Sanofi and Regeneron win appeal to suspended permanent injunction sought by Amgen

- PMLiVE

FDA approves first steroid for Duchenne muscular dystrophy

Marathon Pharma’s Emflaza is first approved to treat all genetic forms of the condition

- PMLiVE

New philosophies driving transformative healthcare

The key trends and philosophies driving this disruptive and innovative era of healthcare forward

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links